In one trial , participants lost about 2% of their body weight after the first month of taking semaglutide
Each tray is worn for about two weeks before advancing to the next
it may progress to central hyperventilation, seizures, coma, and death if left untreated
More than 3,700 lawsuits relating to Ozempic and other GLP-1 weight loss drugs are consolidated into multidistrict litigation (MDL) in Pennsylvania federal court
On 7 April, the FDA published several warning letters, including a batch to companies that the agency said are marketing GLP-1 products, dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) products, and triple agonist (GLP-1/GIP/glucagon) products without regulatory approval
This is called pulmonary aspiration, and it is serious